Navigation Links
Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
Date:11/1/2010

EAST NORRITON, Pa., Nov. 1, 2010 /PRNewswire-FirstCall/ -- Tengion, Inc. (Nasdaq: TNGN) today provided a business update and reported its financial results for the third quarter ended September 30, 2010.

"We recently achieved a major milestone with the implantation of our Neo-Urinary Conduit in the first bladder cancer patient. We and our investigators believe that this first successful implant will facilitate future enrollment," stated Steven Nichtberger, M.D., Tengion President and CEO.  "We are also making significant progress in our kidney program.  Our scientists have now published or presented consistently positive data demonstrating stabilization and preservation of kidney function in four different animal models of kidney failure, including early data from a large animal model of chronic kidney disease.  We look forward to presenting additional data at scientific sessions next month."

Neo-Urinary Conduit Bladder Cancer Trial - Clinical UpdateThe Company's Neo-Urinary Conduit was recently implanted in the first patient as part of the ongoing initial clinical trial evaluating the Company's lead product candidate in bladder cancer patients requiring a urinary diversion following bladder removal.

The implantation of the first patient with the Neo-Urinary Conduit demonstrates the Company's ability to successfully procure an appropriate fat biopsy, ship the biopsy, isolate and expand selective regenerative cells to manufacture the Neo-Urinary Conduit, release the final product within quality control specifications, ship the final product to the hospital and have the Neo-Urinary Conduit implanted using the intended surgical procedure.

Neo-Kidney Augment Program UpdateThe Neo-Kidney Augment is the Company's lead preclinical program and is intended to prevent or delay the need for dialysis or kidney transplant by increasing functional
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
2. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
3. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
4. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
5. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
6. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
7. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
8. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
9. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- World ... aligned with the latest trends and events, companies ... can predict where an industry is headed next, ... (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... with market research publisher GlobalData, offer decision makers ...
(Date:5/22/2013)... and MUNICH , May 22, 2013 /PRNewswire/ ... marketer of transcatheter aortic valve implantation (TAVI) systems for the ... results of the J enaValve Eval U ation of ... Pa T ients with S E vere Ao R tic ... . JUPITER is a post-market registry to evaluate five-year long ...
(Date:5/22/2013)... May 22, 2013  Milliman, Inc., a premier global ... its 2013 Milliman Medical Index (MMI), which measures the ... receiving healthcare benefits through an employer-sponsored preferred provider organization ... family in 2013 is $22,030. "For ... year on a percentage basis was the lowest in ...
Breaking Medicine Technology:Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2
... Liberate Cosmetic Surgery hopes to raise awareness of ... confidence within the cosmetic surgery industry through the launch of ... their on-going activity on the subject, such as question and ... launching some exciting new initiatives online, that it hopes people ...
... 2011 The U.S. Food and Drug Administration ... (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Schizophrenia ... About 1 percent of Americans have this illness. ...
Cached Medicine Technology:Liberate Cosmetic Surgery aims to Highlight Cosmetic Surgery Industry Issues 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 3
(Date:5/22/2013)... ANN ARBORA University of Michigan study challenges previous ... League Baseball. , The study, a collaboration between ... and Florida, looks deeper into the controversial argument ... more strikes for pitchers of the same race. ... claim, said Jason Winfree, associate professor of sport ...
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Over the next ... United States is expected to more than double, topping ... research. The main factor driving the increase: an ... (AHA) and the American Stroke Association, was published May ... will absolutely strain the health care system," Dr. Bruce ...
(Date:5/22/2013)... may be reaping enormous income for patients whose ... contracted in their intensive care units. , In ... American Journal of Medical Quality , the ... an avoidable central line-associated bloodstream infection (CLABSI) costs ... a similar infection-free patient. Moreover, hospitals earn nearly ...
(Date:5/22/2013)... Phelps Memorial Hospital Center in Sleepy ... Center for individuals who would like to be screened ... is the deadliest form of cancer for both men and ... from lung cancer than from breast, colon and prostate cancer ... survival rates. It is well established that routine mammography ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Hurricane preparation ... your home. That’s why Amica Insurance is ... for the upcoming hurricane season. , “An important part ... Bryan Cook, a senior assistant vice president at Amica ... is before the threat of a storm.” , Flood ...
Breaking Medicine News(10 mins):Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2
... Peake: VA Reaches Out to Vets, Families in ... veterans and,their families during major emergencies, especially natural ... to deploy mobile pharmacies,that will provide vital medicine ... will also open up the facilities to help ...
... ACCU-CHEK(R) Aviva System is the first blood glucose monitoring system ... ... Foundation has,awarded its Ease-of-Use Commendation to the ACCU-CHEK(R) Aviva system,making ... Both the ACCU-CHEK Aviva meter and test strips and ...
... data from the SCIAMACHY instrument aboard ESA,s Envisat environmental ... elevated atmospheric carbon dioxide the most important greenhouse ... manmade emissions. , More than 30 billion tonnes of ... the atmosphere annually by human activities, mainly through the ...
... Remuda Programs for Eating Disorders,( http://www.remudaranch.com ), the ... and girls suffering from eating disorders,reports families often ... and,healing of eating disorders., "Part of our ... through a patient,s stay at Remuda," said Amy ...
... ... Industry, ... in convincing private insurers to adopt home,health monitoring technologies. Yet vendors ... education,regarding the benefits of home health monitoring technologies, according to,Private Insurance ...
... Systems,Corporation (NYSE: PER ) and ChinaSoft International ... develop mutually,beneficial opportunities in the Chinese Healthcare market., ... to take our broad,Healthcare IT expertise into the ... relationship with ChinaSoft in order to evaluate and,pursue ...
Cached Medicine News:Health News:VA Putting Mobile Pharmacies on the Road 2Health News:ACCU-CHEK(R) Aviva System Receives Arthritis Foundation's Ease-of-Use Commendation 2Health News:ACCU-CHEK(R) Aviva System Receives Arthritis Foundation's Ease-of-Use Commendation 3Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 2Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 3Health News:Families Play a Role in the Development of Eating Disorders 2Health News:New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies 2Health News:New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies 3Health News:Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities 2
Images from DP micro video cameras can be displayed on high quality 14 ins and 20 ins color monitors, which offer superior picture performance and effective operation functions....
... monitors are designed specifically for medical environments. ... technology with professional monitors, the LMD-151MD offer ... safety requirements and are ideal for use ... more. Slim and light, they can be ...
... Major advancement in craniomaxillofacial fixation. Completely resorbable, ... titanium. Today, it is the most thoroughly ... available as LactoSorb SE, with system enhancements ... LactoSorb SEs streamlined delivery system means that ...
PoleStar N-10 is a compact MRI unit that does not require a specially constructed surgery suite. The magnetic field is confined to the volume between the magnet poles and it's immediate neighborhood....
Medicine Products: